VBN group | HBN group | P | |
---|---|---|---|
Lobe# | |||
Right upper lobe, No. (%) | 10 (23.81%) | 10 (20.83%) | 0.17 |
Right middle lobe, No. (%) | 10 (23.81%) | 4 (8.4%) | |
Right upper lobe, No. (%) | 10 (23.81%) | 18 (37.50%) | |
Left upper lobe, No. (%) | 2 (4.76%) | 6 (12.50%) | |
Left upper lobe, No. (%) | 10 (23.81%) | 10 (20.83%) | |
Location of lesion (IQR), generation* | 6.60 (4–9) | 6.44 (5–9) | 0.50 |
Lesion size (IQR), mm* | 22.19 (10.87–30.00) | 20.19 (7.54–29.94) | 0.15 |
Radiographic lesion type | |||
Solid | 32 (76.19%) | 33 (68.75%) | 0.13 |
Subsolid | 10 (23.81%) | 15 (31.25%) | |
RP-EBUS position | |||
Within the lesion | 31 (73.81%) | 35 (72.92%) | 0.92 |
Adjacent to the lesion | 11(26.19%) | 13 (27.08%) | |
Distance to pleura (IQR), cm* | 10.50 (2.10–23.50) | 8.70 (0.08–17.55) | 0.28 |
Time of planning pathway, min* | 9.79 (6.83–13.97) | 1.32 (0.50–2.55) | < 0.001 |
Total operation time, min* | 28.02 (20.92–41.48) | 23.63 (5.48–24.55) | 0.002 |
Operating cost (RMB)* | 8229.44 ± 772.95 | 5041.97 ± 832.51 | < 0.001 |